TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32944940

Group type: EXPERIMENTAL
Intervention: Cold cabbage leaves
Number of subjects: 2170

Group type: EXPERIMENTAL
Intervention: Room temperature cabbage leaves
Number of subjects: 2170

Group type: EXPERIMENTAL
Intervention: Herbal compress
Number of subjects: 2170

Group type: EXPERIMENTAL
Intervention: Massage therapy plus cactus and aloe compress
Number of subjects: 2170

Group type: EXPERIMENTAL
Intervention: Cactus and aloe cold compress
Number of subjects: 2170

Group type: EXPERIMENTAL
Intervention: Massage plus cactus and aloe cold compress
Number of subjects: 2170

Group type: EXPERIMENTAL
Intervention: Protease
Number of subjects: 2170

Group type: EXPERIMENTAL
Intervention: Serrapeptase
Number of subjects: 2170

Group type: EXPERIMENTAL
Intervention: Cold gel packs
Number of subjects: 2170
Study: 33851682

Group type: EXPERIMENTAL
Intervention: Conventional stainless steel crown restoration
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Hall technique
Number of subjects: 25

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 25
Study: 35905867

Group type: EXPERIMENTAL
Intervention: Digital users (n=368)
Number of subjects: 2431

Group type: COMPARATOR
Intervention: Matched nonusers (n=368)
Number of subjects: 2431
Study: 33709626

Group type: EXPERIMENTAL
Intervention: ModraDoc006/r 30-20/100-100 (30 mg once weekly with ritonavir 100 mg in the morning, and 20 mg with ritonavir 100 mg in the evening)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: ModraDoc006/r 30-20/200-200
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: ModraDoc006/r 30-20/200-100
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: ModraDoc006/r 20-20/200-100
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: ModraDoc006/r (various cohorts)
Number of subjects: 20
Study: 32212800

Group type: EXPERIMENTAL
Intervention: m-DCF regimen (docetaxel 40 mg/m2, cisplatin 40 mg/m2, 5-fluorouracil 400 mg/m2)
Number of subjects: 40

Group type: COMPARATOR
Intervention: EOX regimen (epirubicin 50 mg/m2, oxaliplatin 130 mg/m2, capecitabine 625 mg/m2)
Number of subjects: 40

Group type: COMPARATOR
Intervention: EOX regimen
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: m-DCF and EOX regimens
Number of subjects: 40
Study: 34294642

Group type: EXPERIMENTAL
Intervention: Sodium thiosulfate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 0
Study: 34583675

Group type: EXPERIMENTAL
Intervention: CRP ≤ 22 mg/L combined with rhinorrhea
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: PCT ≤ 0.18 ng/mL combined with rhinorrhea
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: CRP ≤ 22 mg/L and PCT ≤ 0.18 ng/mL combined with rhinorrhea
Number of subjects: 209
Study: 32720546

Group type: EXPERIMENTAL
Intervention: 2 mg nicotine lozenge
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo lozenge
Number of subjects: 68
Study: 35288387

Group type: EXPERIMENTAL
Intervention: Plasma-Lyte 148
Number of subjects: 144

Group type: COMPARATOR
Intervention: Current intravenous fluid care
Number of subjects: 144
Study: 35933415

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) 150 mg oil twice daily (300 mg daily) for 8 days before chemotherapy
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) with CAPOX
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no CBD)
Number of subjects: 54
Study: 34147245

Group type: EXPERIMENTAL
Intervention: Neuromuscular block using rocuronium (mean dose 12.7 mg, 0.7 mg kg−1)
Number of subjects: 66

Group type: COMPARATOR
Intervention: No neuromuscular block
Number of subjects: 66
Study: 32346274

Group type: EXPERIMENTAL
Intervention: Four-session group intervention
Number of subjects: 62

Group type: COMPARATOR
Intervention: One-session informational group intervention
Number of subjects: 62
Study: 34826148

Group type: EXPERIMENTAL
Intervention: Oral fexofenadine combined with topical treatment (topical tacrolimus 0.03–0.1% ointment once daily, topical fluticasone propionate 0.05% cream once daily, paraffin‐based emollients) for 8 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Topical treatment only (topical tacrolimus 0.03–0.1% ointment once daily, topical fluticasone propionate 0.05% cream once daily, paraffin‐based emollients) for 8 weeks
Number of subjects: 50
Study: 32051005

Group type: EXPERIMENTAL
Intervention: Mi Puente intervention (includes usual care materials and processes, inpatient visits, and up to 4 weeks of follow-up phone calls)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (best-practice discharge processes including educational materials, assistance with outpatient appointments, referrals to community-based providers)
Number of subjects: 0
Study: 34203924

Group type: EXPERIMENTAL
Intervention: Therapies with transference interpretations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Therapies without transference interpretations
Number of subjects: 0
Study: 32988624

Group type: EXPERIMENTAL
Intervention: Olaparib (300mg oral tablets, twice daily for 28 days)
Number of subjects: 31
Study: 35692186

Group type: EXPERIMENTAL
Intervention: THC (13-49 mg)
Number of subjects: 85
Study: 33076928

Group type: EXPERIMENTAL
Intervention: Olyset® Net
Number of subjects: 254

Group type: COMPARATOR
Intervention: DawaPlus® 2.0
Number of subjects: 254
Study: 33097097

Group type: EXPERIMENTAL
Intervention: NIATx-TI implementation strategy (change management training and coaching on mobile application use)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Typical software product training (in-person staff training followed by online support)
Number of subjects: 46
Study: 36158972

Group type: EXPERIMENTAL
Intervention: Real acupuncture treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham acupuncture control
Number of subjects: 60
Study: 35896910

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy plus usual care (RTUC)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 160
Study: 33243221

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg or 25 mg)
Number of subjects: 7020

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7020
Study: 34074815

Group type: EXPERIMENTAL
Intervention: Tip-in EMR
Number of subjects: 82

Group type: COMPARATOR
Intervention: EMR
Number of subjects: 82

Group type: COMPARATOR
Intervention: Tip-in EMR vs EMR
Number of subjects: 82
Study: 32678211

Group type: EXPERIMENTAL
Intervention: High rebound (HR) mattress toppers
Number of subjects: 74

Group type: COMPARATOR
Intervention: Low rebound (LR) mattress toppers
Number of subjects: 74

Group type: COMPARATOR
Intervention: Spring mattresses without a topper
Number of subjects: 74
Study: 36198292

Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Combination of TRE and HIIT (TREHIIT)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control group (non-intervention)
Number of subjects: 131
Study: 33572738

Group type: EXPERIMENTAL
Intervention: Flywheel strength training (FST)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Traditional strength training (TST)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 36
Study: 32660494

Group type: EXPERIMENTAL
Intervention: Korean tariff
Number of subjects: 12085

Group type: EXPERIMENTAL
Intervention: Chinese (city) tariff
Number of subjects: 12085

Group type: EXPERIMENTAL
Intervention: US tariff
Number of subjects: 12085

Group type: EXPERIMENTAL
Intervention: UK tariff
Number of subjects: 12085

Group type: EXPERIMENTAL
Intervention: Japanese tariff
Number of subjects: 12085
Study: 35683991

Group type: EXPERIMENTAL
Intervention: Fish powder
Number of subjects: 238

Group type: COMPARATOR
Intervention: Sorghum powder (control)
Number of subjects: 238
Study: 33765912

Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg/month (240 mg loading dose)
Number of subjects: 462
Study: 34776146

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program (MCEP) performed twice weekly for two months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (CG) did not perform any exercise intervention
Number of subjects: 40
Study: 32408817

Group type: EXPERIMENTAL
Intervention: IMR > 40
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: RRR
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: CFR
Number of subjects: 440
Study: 33857789

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 32013332

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 220

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 220
Study: 32852574

Group type: EXPERIMENTAL
Intervention: Duloxetine (40 mg BID) + innovative pelvic floor muscle training (iPFMT)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Duloxetine (40 mg BID)
Number of subjects: 158
Study: 36448245

Group type: EXPERIMENTAL
Intervention: SDM intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: No discernible SDM form
Number of subjects: 100

Group type: COMPARATOR
Intervention: One SDM form
Number of subjects: 100

Group type: COMPARATOR
Intervention: Two SDM forms
Number of subjects: 100

Group type: COMPARATOR
Intervention: Three or more SDM forms
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 34050197

Group type: EXPERIMENTAL
Intervention: Dose 1 Curry (D1C) - 6g mixed spices
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dose 2 Curry (D2C) - 12g mixed spices
Number of subjects: 15

Group type: COMPARATOR
Intervention: Dose 0 Control (D0C) - low-polyphenol, no spices
Number of subjects: 15
Study: 35190536

Group type: EXPERIMENTAL
Intervention: Calorie-restricted modified MIND diet
Number of subjects: 40

Group type: COMPARATOR
Intervention: Calorie-restricted standard control diet
Number of subjects: 40
Study: 33326969

Group type: EXPERIMENTAL
Intervention: Non-selective carious tissue removal (NSCR)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Selective carious tissue removal (SCR)
Number of subjects: 107
Study: 32675074

Group type: EXPERIMENTAL
Intervention: Real training with BCI to control a virtual hand image
Number of subjects: 12

Group type: COMPARATOR
Intervention: Random training with the same hand image controlled by randomly changing values
Number of subjects: 12
Study: 36242060

Group type: EXPERIMENTAL
Intervention: Whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus
Number of subjects: 102

Group type: COMPARATOR
Intervention: Whole brain radiotherapy for sequential brain metastases to boost irradiation
Number of subjects: 102
Study: 32900266

Group type: EXPERIMENTAL
Intervention: Acute ketamine dosing
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Maintenance ketamine therapy (1 mg/kg, once or twice weekly for 3 months)
Number of subjects: 24
Study: 35522253

Group type: EXPERIMENTAL
Intervention: Physical Activity Group (PAG) - two weekly group exercise sessions and two to three home-based exercise sessions per week
Number of subjects: 56
Study: 34900188

Group type: EXPERIMENTAL
Intervention: Targeted nursing intervention centering on narrative nursing (Group A)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Targeted nursing intervention (Group B)
Number of subjects: 120
Study: 33295128

Group type: EXPERIMENTAL
Intervention: Bilateral erector spinae plane block using 20 mL bupivacaine 0.25% at the level of the T7 transverse process
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bilateral sham block using 20 mL normal saline
Number of subjects: 60
Study: 32410819

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of 150 mg of econazole with 6 mg of benzydamine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Econazole single-drug formulation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Benzydamine single-drug formulation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 35797104

Group type: EXPERIMENTAL
Intervention: FutureMe intervention (physical activity and food purchase tracking mobile phone app with future-self avatar)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: FutureMe intervention
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (conventional text- and graphic-based primary interface intervention)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 95
Study: 34293615

Group type: EXPERIMENTAL
Intervention: FFC group: tap water containing FFC (0.15g/L) given daily for 5 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group: normal drinking water and feed given daily
Number of subjects: 60
Study: 36186931

Group type: EXPERIMENTAL
Intervention: 15 mg Crocus sativus capsules twice daily
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 32229745

Group type: EXPERIMENTAL
Intervention: Small-fragment plating (3.5-mm locking compression plate)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Mini-fragment plating (2.7-mm reconstruction plates)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Mini-fragment plating
Number of subjects: 122

Group type: COMPARATOR
Intervention: Small-fragment plating
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 122
Study: 35704951

Group type: COMPARATOR
Intervention: Lu AF11167 3-4mg
Number of subjects: 162

Group type: COMPARATOR
Intervention: Lu AF11167 1-2mg
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 162

Group type: COMPARATOR
Intervention: Lu AF11167 (both doses)
Number of subjects: 162
Study: 32354987

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 4401

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4401
Study: 36630000

Group type: EXPERIMENTAL
Intervention: mAFA intervention (mobile health technology integrated care based on the ABC pathway)
Number of subjects: 3324

Group type: EXPERIMENTAL
Intervention: mAFA intervention
Number of subjects: 3324
Study: 32926423

Group type: EXPERIMENTAL
Intervention: Thermal softening of endotracheal tubes
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group (endotracheal tubes without thermal softening)
Number of subjects: 196
Study: 32089436

Group type: EXPERIMENTAL
Intervention: Anterior circulation ICAS
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Posterior circulation ICAS
Number of subjects: 449
Study: 35297136

Group type: EXPERIMENTAL
Intervention: Mindfulness (measured by Child and Adolescent Mindfulness Measure - CAMM)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Mindfulness (measured by CAMM)
Number of subjects: 152
Study: 34587980

Group type: EXPERIMENTAL
Intervention: Self-regulation and coping strategies in boys with Barth syndrome as explored through qualitative interviews.
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Qualitative exploration of interpersonal processes in family life related to Barth syndrome.
Number of subjects: 11
Study: 32193277

Group type: EXPERIMENTAL
Intervention: BLTR with a 3 mm incision height
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BLTR with a 5 mm incision height
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PLTR with a 3 mm incision height
Number of subjects: 0
Study: 36054287

Group type: EXPERIMENTAL
Intervention: Preoperative FOCUS
Number of subjects: 338

Group type: COMPARATOR
Intervention: No preoperative FOCUS (Control)
Number of subjects: 338
Study: 32299300

Group type: EXPERIMENTAL
Intervention: Quill self‐retaining sutures
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Retromuscular mesh
Number of subjects: 52

Group type: COMPARATOR
Intervention: Both surgical groups
Number of subjects: 52
Study: 35793881

Group type: EXPERIMENTAL
Intervention: Short needling
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 68
Study: 33979487

Group type: EXPERIMENTAL
Intervention: Tympanostomy-tube placement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical management (episodic antimicrobial treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tympanostomy-tube placement (per-protocol analysis)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical management (per-protocol analysis)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tympanostomy-tube placement and Medical management
Number of subjects: 0
Study: 32250190

Group type: EXPERIMENTAL
Intervention: Topical olopatadine hydrochloride 0.1%
Number of subjects: 77

Group type: COMPARATOR
Intervention: Sterile distilled water (control)
Number of subjects: 77
Study: 35802177

Group type: EXPERIMENTAL
Intervention: Supervised Kegel exercises with bio-feedback training (BT)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Unsupervised Kegel exercises
Number of subjects: 29
Study: 34535867

Group type: EXPERIMENTAL
Intervention: Conflicting health information
Number of subjects: 184

Group type: COMPARATOR
Intervention: Congruent health information
Number of subjects: 184
Study: 32041812

Group type: EXPERIMENTAL
Intervention: Education and multilevel social comparison feedback intervention
Number of subjects: 14000

Group type: COMPARATOR
Intervention: Control units (MTUs of the remaining three sites)
Number of subjects: 14000
Study: 35109889

Group type: EXPERIMENTAL
Intervention: Kangxianhuanji granule, 10 g each time, two times daily for 4 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo granule, 10 g each time, two times daily for 4 weeks
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Kangxianhuanji granule
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo granule
Number of subjects: 80
Study: 34552099

Group type: EXPERIMENTAL
Intervention: Gemcitabine monotherapy
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus ATR inhibitor (berzosertib)
Number of subjects: 57
Study: 35324259

Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) program
Number of subjects: 2457

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2457
Study: 32147894

Group type: EXPERIMENTAL
Intervention: Pinyin GraphoGame intervention for 3 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group received school instruction only for 3 weeks
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Pinyin GraphoGame intervention
Number of subjects: 56
Study: 34890346

Group type: EXPERIMENTAL
Intervention: Gamification training method
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Teach-back training method
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 123
Study: 35419986

Group type: EXPERIMENTAL
Intervention: rhTNFR:Fc PFS (prefilled syringe)
Number of subjects: 82

Group type: COMPARATOR
Intervention: rhTNFR:Fc LYO (lyophilized)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both formulations (rhTNFR:Fc PFS and LYO)
Number of subjects: 82
Study: 33418457

Group type: COMPARATOR
Intervention: SPN-812 (viloxazine extended-release) 100-600 mg/day
Number of subjects: 1397
Study: 35094667

Group type: EXPERIMENTAL
Intervention: 6 mg·kg‐1 caffeine + 10% maltodextrin (CHO+CAFMR)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 6 mg·kg‐1 caffeine (CAFMR)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 10% maltodextrin (CHOMR)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Water (PLA)
Number of subjects: 9
Study: 32734457

Group type: EXPERIMENTAL
Intervention: 68Ga-PSMA-11 PET/CT
Number of subjects: 120

Group type: COMPARATOR
Intervention: TRUS-GB
Number of subjects: 120
Study: 36181783

Group type: EXPERIMENTAL
Intervention: Intuity
Number of subjects: 375

Group type: COMPARATOR
Intervention: ME
Number of subjects: 375
Study: 34938848

Group type: EXPERIMENTAL
Intervention: Take Care of Me program (8-week online integrated treatment with 12 modules)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Take Care of Me program
Number of subjects: 222

Group type: COMPARATOR
Intervention: Online psychoeducational control condition
Number of subjects: 222
Study: 35830497

Group type: COMPARATOR
Intervention: Fitbit Charge HR 3 alone (FB)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Fitbit in combination with behaviour change strategies (FB+)
Number of subjects: 44
Study: 32135143

Group type: EXPERIMENTAL
Intervention: Expedited partner therapy awareness
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Expedited partner therapy prescription receipt
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Willingness to dispense expedited partner therapy prescriptions
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Cost of azithromycin for chlamydia treatment
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Cost of cefixime for gonorrhea treatment
Number of subjects: 335
Study: 35600047

Group type: EXPERIMENTAL
Intervention: Predictive model based on Cox regression analysis
Number of subjects: 1762

Group type: EXPERIMENTAL
Intervention: Training set analysis
Number of subjects: 1762

Group type: EXPERIMENTAL
Intervention: Follow-up of patients
Number of subjects: 1762
Study: 34006157

Group type: EXPERIMENTAL
Intervention: Telemedicine
Number of subjects: 198

Group type: COMPARATOR
Intervention: In-person services
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Healthcare delivery changes due to COVID-19
Number of subjects: 198
Study: 33644992

Group type: COMPARATOR
Intervention: Repository corticotropin injection (RCI) 80 units twice weekly for 12 weeks, followed by either RCI or placebo for another 12 weeks.
Number of subjects: 0
Study: 34663438

Group type: EXPERIMENTAL
Intervention: Turmeric (2 gr/day)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 34118699

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 288
Study: 32851513

Group type: EXPERIMENTAL
Intervention: Desflurane (6.0 vol%)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sevoflurane (1.7 vol%)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (human lung)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oxygenator groups (Terumo, LivaNova, Medtronic, Senko)
Number of subjects: 24
Study: 35709862

Group type: EXPERIMENTAL
Intervention: Endovascular Aneurysm Repair (EVAR) with ASG neck score ≥5
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Endovascular Aneurysm Repair (EVAR) with favorable neck morphology
Number of subjects: 171

Group type: COMPARATOR
Intervention: Receiver operating characteristic analysis
Number of subjects: 171

Group type: COMPARATOR
Intervention: Positive likelihood-ratio
Number of subjects: 171

Group type: COMPARATOR
Intervention: Negative likelihood-ratio
Number of subjects: 171